Skip to main content
Chemfab Alkalis Ltd logo

Chemfab Alkalis Ltd — Investor Relations & Filings

Ticker · CHEMFAB ISIN · INE783X01023 LEI · 3358001VZX74GFCTZW69 BSE.NS Manufacturing
Filings indexed 392 across all filing types
Latest filing 2025-05-30 Board/Management Inform…
Country IN India
Listing BSE.NS CHEMFAB

About Chemfab Alkalis Ltd

https://chemfabalkalis.com/

Chemfab Alkalis Ltd is a chemical manufacturing enterprise specializing in the chlor-alkali sector. The company primarily produces caustic soda (sodium hydroxide) in both lye and flake forms, alongside co-products such as liquid chlorine, hydrochloric acid, sodium hypochlorite, and compressed hydrogen gas. Notably, the organization was a pioneer in implementing energy-efficient membrane cell technology in its production processes. Its product portfolio serves diverse industrial applications, including water treatment, textile processing, paper and pulp manufacturing, aluminum refining, and the production of soaps and detergents. The company emphasizes operational efficiency and environmental compliance through advanced electrolysis techniques and rigorous quality control measures.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges about the appointment of an Additional Independent Director on the company's Board of Directors. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the appointment, including the director's profile and terms. There is no financial data, earnings information, or report attached or referenced as being published. The content is focused on management/board changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 3713 characters, which is consistent with a detailed announcement rather than a full report.
2025-05-30 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the submission of newspaper advertisements of audited financial results for the quarter and year ended March 31, 2025. It references compliance with SEBI Listing Regulations (Regulation 30 and 47). The content includes excerpts from newspaper advertisements and news articles about various corporate and financial events, but the primary purpose is to submit copies of the published audited financial results advertisements. The document does not contain the full audited financial results report itself but rather the advertisement copies of those results. The document length is 15,000 characters, which is substantial, but the content is mainly an announcement of the publication of financial results in newspapers, not the full report or detailed financial statements. According to the "Menu vs Meal" rule, such a document is an announcement or submission of published advertisements of financial results, not the full report. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement related to compliance and disclosure of financial results advertisements under SEBI regulations, and does not contain the full Annual Report or detailed financial statements.
2025-05-17 English
Updates
Investor Presentation Classification · 100% confidence The document is titled as an "Investor Presentation" and is submitted under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. It contains detailed information about the company's business segments, manufacturing infrastructure, strategic initiatives, and growth plans. The text includes forward-looking statements, business overview, product portfolio, and management team details, which are typical contents of an investor presentation. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. There is no indication that this is a regulatory filing, earnings release, or annual/interim report. Therefore, the document fits best into the category of Investor Presentation (IP).
2025-05-15 English
Outcome of Board Meeting
Regulatory Filings
2025-05-14 English
Change in Auditors
Regulatory Filings Classification · 95% confidence The document is a formal communication from the company Chemfab Alkalis Limited to stock exchanges (BSE and NSE) dated 14th May 2025. It reports the outcome of a Board Meeting held on the same day. The key points include approval of audited standalone and consolidated financial statements for the quarter and year ended 31st March 2025, declaration of a final dividend, and appointments/reappointments of auditors. The document includes details pursuant to SEBI regulations and is addressed as an official announcement of the Board Meeting outcomes. It does not contain the full financial statements or detailed financial analysis itself but rather the results and decisions made by the Board. The document length is about 5407 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement of board meeting outcomes including financial results approval and auditor appointments, but not the full Annual Report or standalone Audit Report.
2025-05-14 English
Dividend
Regulatory Filings
2025-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.